Batey R G, Lai Chung Fong P, Shamir S, Sherlock S
Dig Dis Sci. 1980 May;25(5):340-6. doi: 10.1007/BF01308057.
The nature of iron in the serum of patients with idiopathic hemochromatosis has been studied utilizing an isotope labeling method and results have been compared with those from normal individuals and patients with other forms of liver disease. Between 2 and 4% of a tracer dose of 59Fe added to normal serum was retained by DEAE Sephadex and has been designated non-transferrin-bound. Alcoholic liver disease, chronic active hepatitis, and iron deficiency have no effect on this fraction. In idiopathic hemochromatosis 34.6 +/- 3.9% of the added iron was not bound to transferrin at diagnosis, representing approximately 700 microgram Fe/liter serum. Treatment lowers this fraction before serum iron concentration falls to normal. The majority of the non-transferrin-bound iron is of low molecular weight and is not bound to albumin. The presence of this fraction may contribute significantly to the development of tissue siderosis.
利用同位素标记法研究了特发性血色素沉着症患者血清中铁的性质,并将结果与正常人和其他形式肝病患者的结果进行了比较。添加到正常血清中的示踪剂量的59Fe有2%至4%被DEAE葡聚糖凝胶保留,被称为非转铁蛋白结合铁。酒精性肝病、慢性活动性肝炎和缺铁对这一部分没有影响。在特发性血色素沉着症中,诊断时添加的铁有34.6±3.9%未与转铁蛋白结合,相当于血清中约700微克铁/升。治疗可使这一部分在血清铁浓度降至正常之前降低。大多数非转铁蛋白结合铁分子量较低,且未与白蛋白结合。这一部分的存在可能对组织铁沉积症的发展有显著影响。